Reproductive biotechnology company Memphasys (ASX: MEM) has accelerated its FelixTM System sales orders in Japan, under its exclusive agreement with Vitrolife Japan KK, to sell and distribute the FelixTM System | ASX announcement: https://announcements.asx.com.au/asxpdf/20240318/pdf/061lr49l0r8k8h.pdf
No gainer or loser data available.
